Trial Profile
Metabolic Signatures and Biomarkers in First Episode and Recurrent Patients With Schizophrenia in Comparison to Healthy Controls
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Adverse reactions; Biomarker
- 10 Jul 2007 New trial record.